Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 9, 2024Advanced Healthcare Materials

Cell Membrane‐Targeting Type I/II Photodynamic Therapy Combination with FSP1 Inhibition for Ferroptosis‐Enhanced Photodynamic Immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJian ChenZDZeyu DuanLDLidong Deng

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e79c4cb6db64358770b862https://doi.org/10.1002/adhm.202304436
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synergizing Ferroptosis Suppressor Protein 1 Gene Silencing and Photodynamic Therapy Based on Photosensitive Lipid Nanoparticles for Colon Cancer Immunotherapy.2025 · 14 citations
  2. 2Lipid Droplets‐Targeted Thermally Activated Delayed Fluorescence Photosensitizer for Photodynamic Therapy‐Mediated Ferroptosis: a New Strategy for Tumor Radiosensitization2025
  3. 3Lipid Droplets‐Targeted Thermally Activated Delayed Fluorescence Photosensitizer for Photodynamic Therapy‐Mediated Ferroptosis: a New Strategy for Tumor Radiosensitization2025 · 1 citations
  4. 4Anion‐π <sup>+</sup> Type AIE‐Active Photosensitizers for Ferroptosis‐Driven Photodynamic Immunotherapy Against Hypoxic Solid Tumors2026 · 5 citations
  5. 5Photothermal Sensitive Nano Heterojunction Triggering Ferroptosis and PANoptosis for Improving Tumor Immunotherapy2026 · 2 citations